Patrick Lin
Equibles does not estimate personal net worth.
Get an email with a short summary when Processa Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get PCSA alertsAbout Patrick Lin
The proxy statement of Processa Pharmaceuticals, Inc. reports total compensation of $1,042,778 for Patrick Lin in fiscal 2022, including a base salary of $93,875. Disclosed compensation is on record for 4 fiscal years. Processa Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Processa Pharmaceuticals, Inc. includes George Ng (CEO and Board Member), Russell L. Skibsted (CFO), Russell Skibsted (CFO) and 7 others.
Affiliation history
-
Processa Pharmaceuticals, Inc. (PCSA)
Proxy statement
CurrentStart not stated–present
Last confirmed June 18, 2026
Company network
Leadership on record at Processa Pharmaceuticals, Inc.
- George Ng CEO, Board Member
- Russell L. Skibsted CFO
- Russell Skibsted CFO
- David Young Board Member
- Geraldine Pannu Board Member
- James Neal Board Member
- James R. Neal Board Member
- Justin Yorke Board Member
- Khoso Baluch Board Member
- Sheila Gujrathi Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Business and Strategy Officer | $93,875 | $1,042,778 |
| 2021 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Business and Strategy Officer | $87,500 | $456,467 |
| 2020 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Business and Strategy Officer | $75,492 | $476,228 |
| 2019 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Business and Strategy Officer | $52,500 | $215,702 |
Recent activity
No call appearances or filed executive changes recorded yet.